These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
378 related articles for article (PubMed ID: 33539863)
1. Tacrolimus Use and COVID-19 Infection in Patients After Solid Organ Transplantation. Yin S; Wang X; Song T Gastroenterology; 2021 Aug; 161(2):728-730.e1. PubMed ID: 33539863 [No Abstract] [Full Text] [Related]
2. Practical Consideration for Drug Monitoring of Tacrolimus in Liver Transplantation Recipients with SARS-CoV-2 Infection. Joshi T; Rana A; Vierling JM; Kanwal F; Goss JA; Cholankeril G Liver Transpl; 2022 Jan; 28(1):127-130. PubMed ID: 34416083 [No Abstract] [Full Text] [Related]
6. Clinical insights into the role of immunosuppression in solid organ transplant recipients with COVID-19. Kolonko A; Kuczaj AA; Musialik J; Słabiak-Błaż N; Hrapkowicz T; Przybyłowski P; Więcek A Pol Arch Intern Med; 2022 Nov; 132(2):. PubMed ID: 34779600 [TBL] [Abstract][Full Text] [Related]
7. Molecular mechanisms of FK506-induced hypertension in solid organ transplantation patients. Wang J; Guo R; Liu S; Chen Q; Zuo S; Yang M; Zuo X Chin Med J (Engl); 2014; 127(20):3645-50. PubMed ID: 25316243 [TBL] [Abstract][Full Text] [Related]
8. Immunosuppressant Use and Gout in the Prevalent Solid Organ Transplantation Population. Brigham MD; Milgroom A; Lenco MO; Wang Z; Kent JD; LaMoreaux B; Johnson RJ; Mandell BF; Hadker N; Sanchez H; Francis K; Radeck LP; Miyasato G; Li JW Prog Transplant; 2020 Jun; 30(2):103-110. PubMed ID: 32208882 [TBL] [Abstract][Full Text] [Related]
9. Effect of immunosuppression maintenance in solid organ transplant recipients with COVID-19: Systematic review and meta-analysis. Karruli A; Spiezia S; Boccia F; Gagliardi M; Patauner F; Salemme A; Maiello C; Zampino R; Durante-Mangoni E Transpl Infect Dis; 2021 Aug; 23(4):e13595. PubMed ID: 33641202 [TBL] [Abstract][Full Text] [Related]
10. Topical steroids and topical tacrolimus appear safe regarding the COVID-19 epidemic. Souaid K; Klejtman T; Kramkimel N; Isnard C; Dupin N; Aractingi S Ann Dermatol Venereol; 2021 Jun; 148(2):122-123. PubMed ID: 33551212 [No Abstract] [Full Text] [Related]
12. Letter to the Editor: Autoimmune Hepatitis and Coronavirus Disease 2019: Disease Outcomes and Tacrolimus Use. Ng AC Hepatol Commun; 2021 Oct; 5(10):1801-1802. PubMed ID: 34222740 [No Abstract] [Full Text] [Related]
13. Catatonia as a manifestation of tacrolimus-induced neurotoxicity in organ transplant patients: a case series. Chopra A; Das P; Rai A; Kuppuswamy PS; Li X; Huston J; Philbrick K; Sola C Gen Hosp Psychiatry; 2012; 34(2):209.e9-11. PubMed ID: 21937118 [TBL] [Abstract][Full Text] [Related]
14. Food allergy after pediatric organ transplantation with tacrolimus immunosuppression. Nowak-Wegrzyn AH; Sicherer SH; Conover-Walker MK; Wood RA J Allergy Clin Immunol; 2001 Jul; 108(1):146-7. PubMed ID: 11447402 [No Abstract] [Full Text] [Related]
15. Risk of Breakthrough SARS-CoV-2 Infections in Adult Transplant Recipients. Qin CX; Moore LW; Anjan S; Rahamimov R; Sifri CD; Ali NM; Morales MK; Tsapepas DS; Basic-Jukic N; Miller RA; van Duin D; Santella RN; Wadei HM; Shah PD; Gage N; Malinis M; Aslam S; Todesco E; Werbel WA; Avery RK; Segev DL Transplantation; 2021 Nov; 105(11):e265-e266. PubMed ID: 34310531 [No Abstract] [Full Text] [Related]
16. [Is it possible to prevent kidney problems caused by immunosuppression?]. Aitio ML Duodecim; 2000; 116(5):511-9. PubMed ID: 11787104 [No Abstract] [Full Text] [Related]
17. Impact of immunosuppressive regimes on posttransplant diabetes mellitus. Weir M Transplant Proc; 2001 Aug; 33(5A Suppl):23S-26S. PubMed ID: 11498201 [No Abstract] [Full Text] [Related]
18. Transplantation in the era of the Covid-19 pandemic: How should transplant patients and programs be handled? NasrAllah MM; Osman NA; Elalfy M; Malvezzi P; Rostaing L Rev Med Virol; 2021 Jan; 31(1):1-9. PubMed ID: 32954602 [TBL] [Abstract][Full Text] [Related]